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A Closer Look on the Battleﬁeld
The Salvaged Area at Risk as an Outcome Marker for
Myocardial Reperfusion*
Matthias G. Friedrich, MD
Calgary, Alberta, CanadaAcute myocardial infarction requires immediate
reperfusion, because an open artery will likely im-
prove the status and the prognosis of the patient.
The potential benefit of acute revascularization for
cellular and functional recovery, quality of life, and
prognosis, however, might be lost within hours after
occlusion (1), and the role of reperfusion strategies
with respect to time of onset of symptoms is still
being discussed (2).
See page 569
The clinical and scientific assessment of the
success of acute revascularization (i.e., myocardial
salvage) currently uses surrogate markers such as the
angiographic appearance of the coronary arteries,
relief of symptoms, troponin or creatine kinase
kinetics, and the electrocardiogram. These markers,
however, do not very accurately or even quantita-
tively reflect myocardial salvage. Therefore, research
on reperfusion strategies, although abundant, has
been challenged by a demand for large sample sizes
and long follow-up periods. With respect to pre-
procedural risk markers, timing of reperfusion, re-
vascularization techniques, as well as peri- and
post-interventional patient management, many
questions remain unanswered. Better markers of
myocardial salvage are sorely needed for clinical
application and research.
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the Department of Cardiac Sciences and Radiology, University of
Calgary, Calgary, Alberta, Canada. Dr. Friedrich is a consultant and
shareholder of Circle Cardiovascular Imaging Inc., Calgary, a company
commercializing cardiac magnetic resonance image evaluation software.In the study published in this issue of iJACC,
Carlsson et al. (3) report a cardiac magnetic reso-
nance (CMR) study including T2-weighted imag-
ing and late gadolinium enhancement for visualiz-
ing and quantifying myocardial salvage. Sixteen
patients with first and acute ST-segment elevation
infarction were studied at days 1 and 7 as well as 6
weeks and 6 months after the event. The presence,
location, and volumetric extent of the area at risk
were compared with 99mTc-tetrofosmin single-
photon emission computed tomography studies
done before the revascularization. The authors
found an excellent agreement between both meth-
ods within the first week. As expected, the increased
signal intensity seen on T2-weighted CMR images
largely disappeared within 6 weeks. The authors
conclude that T2-weighted CMR of acute reper-
fused infarction not only correctly determines the
area at risk within 1 week after the event but—in
combination with late gadolinium enhancement
images acquired during the same CMR session—
also quantifies myocardial salvage.
The study provides clinical validation of previous
reports on the accuracy and clinical feasibility of
T2-weighted CMR imaging in acute myocardial
infarction (4) and for visualizing the area at risk in
animal models (5). The results validate previous
studies (6,7) applying the combination of T2-
weighed CMR with late gadolinium enhancement
for quantifying myocardial salvage in patients. The
finding that the area at risk was accurately visualized
after 7 days is particularly important and under-
scores the utility of this method for post-procedural
patient follow-up and as an end point for clinical
trials on acute coronary revascularization.
Acute severe ischemia, likely through an increase
of “unbound” water protons after decoupling of
water from intracellular/mitochondrial proteins,
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578eads to prolongation of T1 (8) and T2 (9,10)
elaxation times. In T2-weighted CMR images,
issues with longer T2 appear with higher signal
ntensity, despite the fact that the absolute differ-
nce of tissue water content between edematous and
ormal tissue is small (actually, the water content of
ll body parts is generally very similar yet still
ufficient to cause visible signal differences between
arious tissues in T2-weighted images).
In clinical research, T2-weighted CMR was used
or visualizing acute myocardial infarction in humans
s early as 1985 (11). Its clinical applicability, however,
as limited by its susceptibility to motion artifacts and
ow signal-to-noise properties. Advances in CMR,
owever, have led to improved image quality, and
everal studies have confirmed the utility of T2-
eighted CMR to visualize acute myocardial ischemic
njury (4,7,12–14). Image quality, however, might
ary between scanners and sequence parameter set-
ings. Recent reports indicate that T2-weighted
teady-state free precession techniques might provide
ore consistent image quality and a higher signal-to-
oise ratio (15,16), albeit without improving the
ontrast-to-noise ratio.
The sequence used in this study might be partic-
larly sensitive to water because of its inversion-
ecovery approach (17). 99mTc-tetrofosmin is a
alidated technique to accurately depict the perfu-
ion bed of an occluded artery and therefore—
imited only by its lower spatial resolution—is
uitable as an in vivo standard of truth.
There are some limitations to the study, with the
mall sample size being the most important. The
atient cohort has a surprisingly high rate of com-
lete coronary occlusions, and the proportion of
5% myocardial salvage within the area at risk issingle-photon emission computed to- culation 2006;113:1A more widespread clinical application will depend
n access to scanners and workflows for timely scan-
ing of patients with reperfused acute infarction.
lthough the CMR study itself is safe, the transport
f critically ill and unstable patients to CMR depart-
ents might expose patients to increased risk. Pace-
akers, implanted defibrillators, and other implanted
evices generally preclude patients from CMR stud-
es. Also, in many institutions there is a lack of
xperienced CMR technologists.
Despite some remaining issues, T2-weighted
MR can be considered an important component
f a comprehensive CMR study in patients with
cute reperfused infarcts. Knowledge about myocar-
ial salvage might improve clinical decision-making
nd quality management. Myocardial salvage as a
arker for success would enable us to more effi-
iently investigate interventional strategies, proce-
ures, peri-interventional care, and devices.
The study by Carlsson et al. (3) provides impor-
ant clinical validation for this concept.
Other clinical settings might also benefit from
his approach, such as imaging edema in patients
ith unstable angina.
CMR is emerging as the most accurate noninva-
ive tool to quantitatively assess myocardial salvage.
n addition to the versatility and safety of CMR, its
tility as a comprehensive tool for the assessment of
ardiac morphology, function, and tissue character-
stics will continue to increase its clinical role.
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